Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Divalproex ER Combinations for Mania
NCT00183443Phase 3Completed
- Sponsor
- Palo Alto Veterans Institute for Research
- Start
- Feb 2005
- Primary completion
- Nov 2010
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of divalproex sodium, lithium and quetiapine in bipolar I disorder and schizophrenia (3 arms), sponsored by Palo Alto Veterans Institute for Research. Primary endpoint: Young Mania Rating Scale at Week 12. Started Feb 2005; status: completed.
02
Drugs
divalproex sodiumlithiumquetiapine
03
Conditions
bipolar I disorderschizophrenia
Beyond the preview
Go deeper on NCT00183443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00183443.